A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer
Clinical trial NCT03519308 · TERMINATED
Trial details
- NCT number
- NCT03519308
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-29
- Primary completion
- 2022-04-18
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.